ReviewCancers2026

Beyond Insulin Resistance: Exploring the Centrality of the Gut-Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes.

Mario Romeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.